Task: Answer the MCQ question.
Question: Which drug exhibits a 28.296% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CSCCC(NC(=O)c1ccc(Cl)cc1Cl)C(=O)OCC(N)=O
b CCOC(=O)N1CCN(Cc2nnc(-c3ccccc3C)o2)CC1.Cl
c CCCOC(=O)Nc1sc2c(c1C(N)=O)CCCC2
Answer: c. CCCOC(=O)Nc1sc2c(c1C(N)=O)CCCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCOC(=O)Nc1sc2c(c1C(N)=O)CCCC2
CCCOC(=O)Nc1sc2c(c1C(N)=O)CCCC2
2-(propoxycarbonylamino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide